CML drugs may change your metabolism – new study investigates
NCT ID NCT07413263
First seen Feb 20, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study will check how tyrosine kinase inhibitors (TKIs), the main drugs for chronic myeloid leukemia (CML), affect blood sugar and cholesterol levels. Researchers will measure changes in HbA1c (a blood sugar marker) and lipid profile (cholesterol and fats) in 75 CML patients. The goal is to understand these side effects better, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.